Published in
Wiley, Hematological Oncology, 1(41), p. 97-107, 2022
DOI: 10.1002/hon.3096
Links
Tools
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B‐cell lymphoma in the rituximab era
Journal article published in 2022 by
Theodoros P. Vassilakopoulos,
Fotios Panitsas 
,
Zois Mellios,
John Apostolidis ,
Michalis Michael,
Ronit Gurion,
Burhan Ferhanoglu ,
Eleftheria Hatzimichael,
Stamatios Karakatsanis ,
Maria Dimou ,
Christina Kalpadakis,
Eirini Katodritou,
Theoni Leonidopoulou,
Ioannis Kotsianidis,
Hara Giatra
and other authors.
,
Zois Mellios,
John Apostolidis ,
Michalis Michael,
Ronit Gurion,
Burhan Ferhanoglu ,
Eleftheria Hatzimichael,
Stamatios Karakatsanis ,
Maria Dimou ,
Christina Kalpadakis,
Eirini Katodritou,
Theoni Leonidopoulou,
Ioannis Kotsianidis,
Hara Giatra
and other authors.
This paper is made freely available by the publisher.
Full text: Download
Published version:
archiving forbidden
Data provided by 